Checchi Capital Advisers’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Buy
1,804
+185
+11% +$36.3K 0.02% 423
2026
Q1
$317K Buy
1,619
+293
+22% +$56.9K 0.02% 457
2025
Q4
$230K Buy
1,326
+70
+6% +$12.7K 0.01% 501
2025
Q3
$239K Sell
1,256
-229
-15% -$40.6K 0.01% 495
2025
Q2
$267K Sell
1,485
-91
-6% -$15.8K 0.01% 480
2025
Q1
$267K Sell
1,576
-37
-2% -$6.08K 0.01% 488
2024
Q4
$243K Sell
1,613
-30
-2% -$4.67K 0.01% 494
2024
Q3
$255K Sell
1,643
-171
-9% -$25.5K 0.01% 487
2024
Q2
$248K Sell
1,814
-78
-4% -$10.7K 0.01% 481
2024
Q1
$252K Buy
1,892
+68
+4% +$8.82K 0.02% 483
2023
Q4
$251K Buy
1,824
+119
+7% +$15.6K 0.02% 470
2023
Q3
$208K Sell
1,705
-293
-15% -$39K 0.02% 501
2023
Q2
$281K Buy
1,998
+59
+3% +$8.13K 0.03% 445
2023
Q1
$274K Buy
1,939
+128
+7% +$18.3K 0.03% 441
2022
Q4
$283K Sell
1,811
-12
-0.7% -$1.72K 0.03% 411
2022
Q3
$224K Sell
1,823
-19
-1% -$2.5K 0.02% 476
2022
Q2
$252K Buy
1,842
+122
+7% +$16.6K 0.02% 478
2022
Q1
$235K Buy
1,720
+262
+18% +$36.5K 0.02% 477
2021
Q4
$252K Buy
1,458
+46
+3% +$7K 0.02% 435
2021
Q3
$205K Buy
+1,412
New +$207K 0.02% 482
2016
Q3
Sell
-876
Closed -$71K 611
2016
Q2
$71K Sell
876
-181
-17% -$13.8K 0.01% 713
2016
Q1
$76K Buy
+1,057
New +$70.9K 0.02% 684

Other funds holding DGX

Checchi Capital Advisers's DGX Position: Q2 2026 in Review

Checchi Capital Advisers increased its Quest Diagnostics (DGX) stake by 11% in Q2 2026, buying an estimated $36.3K and bringing the position to 1,804 shares worth $382K. The position accounts for 0.02% of the portfolio, ranked #423.

Checchi Capital Advisers first reported a position in DGX in Q1 2016 and has held it in 22 quarters since. 629 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Checchi Capital Advisers held 1,804 shares of Quest Diagnostics worth $382K as of Q2 2026.
  • Checchi Capital Advisers bought 185 Quest Diagnostics shares in Q2 2026, an estimated $36.3K.
  • Quest Diagnostics made up 0.02% of Checchi Capital Advisers's portfolio in Q2 2026, its #423 holding.
  • Checchi Capital Advisers first reported a position in Quest Diagnostics in Q1 2016 and has held it in 22 quarters since.
  • 629 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.